Hermann Gram
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Journal: Cardiovascular research
Published: December 22, 2020
A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis.
Journal: Rheumatology (Oxford, England)
Published: August 17, 2020
Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia.
Journal: Cancer immunology research
Published: January 24, 2019
The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer.
Journal: Pharmacological research
Published: December 12, 2018
Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
Journal: Annals of the rheumatic diseases
Published: November 10, 2018
Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.
Journal: European heart journal
Published: May 04, 2018
Neutralization of Interleukin-1β following Diffuse Traumatic Brain Injury in the Mouse Attenuates the Loss of Mature Oligodendrocytes.
Journal: Journal of neurotrauma
Published: April 25, 2018
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice.
Journal: Nature medicine
Published: January 30, 2018
An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome.
Journal: Frontiers in immunology
Published: June 22, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.
Journal: Arthritis research & therapy
Published: April 14, 2016
Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Journal: The Journal of biological chemistry
Published: November 13, 2015
Preclinical characterization and clinical development of ILARIS(®) (canakinumab) for the treatment of autoinflammatory diseases.
Journal: Current opinion in chemical biology
Published: September 22, 2015
Last Updated: 09/26/2026